Aperio Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $187M | Sell |
2,393,982
-58,780
| -2% | -$4.5M | 0.55% | 28 |
|
|
2020
Q3 | $194M | Buy |
2,452,762
+23,053
| +0.9% | +$1.81M | 0.66% | 22 |
|
|
2020
Q2 | $179M | Buy |
2,429,709
+89,442
| +4% | +$6.73M | 0.66% | 21 |
|
|
2020
Q1 | $172M | Sell |
2,340,267
-128,518
| -5% | -$10.1M | 0.76% | 19 |
|
|
2019
Q4 | $214M | Buy |
2,468,785
+175,502
| +8% | +$14.4M | 0.77% | 18 |
|
|
2019
Q3 | $184M | Buy |
2,293,283
+212,176
| +10% | +$17M | 0.73% | 19 |
|
|
2019
Q2 | $167M | Buy |
2,081,107
+90,371
| +5% | +$6.92M | 0.68% | 21 |
|
|
2019
Q1 | $158M | Buy |
1,990,736
+128,587
| +7% | +$9.62M | 0.68% | 21 |
|
|
2018
Q4 | $136M | Buy |
1,862,149
+125,138
| +7% | +$8.83M | 0.68% | 19 |
|
|
2018
Q3 | $118M | Buy |
1,737,011
+62,399
| +4% | +$3.98M | 0.52% | 25 |
|
|
2018
Q2 | $97M | Buy |
1,674,612
+175,508
| +12% | +$9.9M | 0.46% | 30 |
|
|
2018
Q1 | $77.9M | Buy |
1,499,104
+42,631
| +3% | +$2.3M | 0.39% | 45 |
|
|
2017
Q4 | $78.2M | Sell |
1,456,473
-246,768
| -14% | -$13.7M | 0.4% | 43 |
|
|
2017
Q3 | $104M | Buy |
1,703,241
+37,888
| +2% | +$2.3M | 0.59% | 24 |
|
|
2017
Q2 | $102M | Buy |
1,665,353
+111,669
| +7% | +$6.8M | 0.62% | 22 |
|
|
2017
Q1 | $94.2M | Buy |
1,553,684
+56,641
| +4% | +$3.44M | 0.64% | 24 |
|
|
2016
Q4 | $84.1M | Sell |
1,497,043
-172,075
| -10% | -$10.1M | 0.64% | 23 |
|
|
2016
Q3 | $99.4M | Buy |
1,669,118
+55,068
| +3% | +$3.22M | 0.72% | 18 |
|
|
2016
Q2 | $88.7M | Buy |
1,614,050
+216,747
| +16% | +$11.5M | 0.69% | 17 |
|
|
2016
Q1 | $70.5M | Buy |
1,397,303
+122,014
| +10% | +$5.98M | 0.6% | 24 |
|
|
2015
Q4 | $64.3M | Sell |
1,275,289
-23,232
| -2% | -$1.17M | 0.59% | 27 |
|
|
2015
Q3 | $61.2M | Buy |
1,298,521
+16,676
| +1% | +$886K | 0.62% | 22 |
|
|
2015
Q2 | $69.6M | Buy |
1,281,845
+196,589
| +18% | +$11M | 0.72% | 14 |
|
|
2015
Q1 | $59.5M | Buy |
1,085,256
+83,672
| +8% | +$4.74M | 0.67% | 15 |
|
|
2014
Q4 | $54.3M | Buy |
1,001,584
+52,954
| +6% | +$2.95M | 0.67% | 17 |
|
|
2014
Q3 | $53.7M | Buy |
948,630
+78,093
| +9% | +$4.39M | 0.73% | 13 |
|
|
2014
Q2 | $48.1M | Buy |
870,537
+50,889
| +6% | +$2.78M | 0.7% | 15 |
|
|
2014
Q1 | $44.4M | Buy |
+819,648
| New | +$42.4M | 0.62% | 14 |
|
|
2013
Q4 | – | Sell |
-646,828
| Closed | -$29.6M | – | 18 |
|
|
2013
Q3 | $29.4M | Buy |
646,828
+89,064
| +16% | +$4.07M | 0.57% | 18 |
|
|
2013
Q2 | $24.7M | Buy |
+557,764
| New | +$24.9M | 0.59% | 18 |
|
Other funds holding MRK
Aperio Group's MRK Position: Q4 2020 in Review
Aperio Group reduced its Merck (MRK) stake by 2.4% in Q4 2020, selling an estimated $4.5M and leaving 2,393,982 shares worth $187M. The position accounts for 0.55% of the portfolio, ranked #28.
Aperio Group first reported a position in MRK in Q2 2013 and has held it in 30 quarters since. The position peaked at $214M in Q4 2019. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.
- Aperio Group held 2,393,982 shares of Merck worth $187M as of Q4 2020.
- Aperio Group sold 58,780 Merck shares in Q4 2020, an estimated $4.5M.
- Merck made up 0.55% of Aperio Group's portfolio in Q4 2020, its #28 holding.
- Aperio Group first reported a position in Merck in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Merck position peaked at $214M in Q4 2019.
- 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.